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Objective: To determine population-based estimates of coronavirus disease 2019 (COVID-19) in a densely
populated urban community of Karachi, Pakistan.
Methods: Three cross-sectional surveys were conducted in April, June and August 2020 in low- and hightransmission neighbourhoods. Participants were selected at random to provide blood for Elecsys
immunoassay for detection of anti-severe acute respiratory syndrome coronavirus-2 antibodies. A
Bayesian regression model was used to estimate seroprevalence after adjusting for the demographic
characteristics of each district.
Results: In total, 3005 participants from 623 households were enrolled in this study. In Phase 2,
adjusted seroprevalence was estimated as 8.7% [95% conﬁdence interval (CI) 5.1–13.1] and 15.1% (95% CI
9.4–21.7) in low- and high-transmission areas, respectively, compared with 0.2% (95% CI 0–0.7) and 0.4%
(95% CI 0–1.3) in Phase 1. In Phase 3, it was 12.8% (95% CI 8.3–17.7) and 21.5% (95% CI 15.6–28) in low- and
high-transmission areas, respectively. The conditional risk of infection was 0.31 (95% CI 0.16–0.47) and
0.41 (95% CI 0.28–0.52) in low- and high-transmission neighbourhoods, respectively, in Phase 2. Similar
trends were observed in Phase 3. Only 5.4% of participants who tested positive for COVID-19 were
symptomatic. The infection fatality rate was 1.66%, 0.37% and 0.26% in Phases 1, 2 and 3, respectively.
Conclusion: Continuing rounds of seroprevalence studies will help to improve understanding of secular
trends and the extent of infection during the course of the pandemic.
© 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-ncnd/4.0/).

Keywords:
Seroprevalence
Seroepidemiology
COVID-19
Antibody
Surveillance
Pakistan

Introduction
The coronavirus disease 2019 (COVID-19) pandemic has
resulted in more than 62 million conﬁrmed cases and over 1.4
million deaths globally, a case fatality rate (CFR) of approximately
5.4% and an infection fatality rate (IFR) of 0.9% (Johns Hopkins

* Corresponding author at: Department of Paediatrics and Child Health, Aga Khan
University, Stadium Road, Karachi 74800, Pakistan.
E-mail addresses: Imran.nisar@aku.edu (M.I. Nisar), fyezah.jehan@aku.edu
(F. Jehan).

University, 2020; Rekatsina et al., 2020). As the world rushed to
respond to the global health crisis, the pandemic revealed
numerous cracks in healthcare systems (Armocida et al., 2020).
Pakistan was one of the ﬁrst low- and middle-income countries
(LMICs) to be affected by the pandemic, and had reported 398,024
cases and 8025 deaths (CFR 2.51%) at the time of writing
(Government of Pakistan, 2020; Johns Hopkins University,
2020). CFR has been variable, ranging from 5.11% in Khyber
Pakhtunkhwa to 0.71% in Gilgit Baltistan, with rates of 1.82%, 1.80%
and 1.28% reported for Punjab, Sindh and Baluchistan, respectively
(Anser et al., 2020).

https://doi.org/10.1016/j.ijid.2021.03.040
1201-9712/© 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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households as symptomatic individuals are more likely to transmit
the virus (Ferretti et al., 2020; Gudbjartsson et al., 2020; Lavezzo
et al., 2020; Streeck et al., 2020).
Using seroprevalence data, the conditional risk of infection
(CRI; i.e. the probability that an individual in a household is
infected given that another household member is infected) can
serve as a related index of infection within a household (Lavezzo
et al., 2020). Additionally, true estimates of IFR can be calculated as
it is possible to detect asymptomatic and mild cases who did not
seek treatment.
This study estimated changes in seroprevalence in low- and
high-transmission neighbourhoods of Karachi between April and
August 2020 using serial cross-sectional surveys by adapting the
World Health Organization (WHO) UNITY protocol. The estimates
are presented by age and gender, and were used to compute CRI
and IFR (World Health Organization, 2020b).

The demographic characteristics of Pakistan are typical of most
LMICs, with 41% of the population aged <15 years (MahsudDornan, 2007). The societal construct in Pakistan boasts a
patrilineal joint family system, intergenerational co-residence of
family members, and an average household size of six or more
(Rana, 2017). This is important because recent evidence indicates
that households with individuals aged >60 years are at risk of lifethreatening manifestations of the disease (Fenoll and Grossbard,
2020). Karachi is home to people from varying diasporas across
Pakistan, and has been the epicentre of the epidemic since 26
February 2020, reporting the highest number of cases in Pakistan
(84,232) and accounting for 28% of all cases in the country
(Government of Sindh, 2021). Crowded neighbourhoods and urban
slum dwellings, along with poor adherence to mitigation measures
in the city, may have accelerated the transmission of infection
(Wasdani and Prasad, 2020).
Surveillance systems form the basis for tracking cases of
COVID-19, testing populations at risk and performing contact
tracing, thereby representing the key components of the public
health response (World Health Organization, 2020a). Facilitybased surveillance efforts are likely to miss mild and asymptomatic
cases, as bolstered by evidence from a WHO–China Joint
Commission Report and several published studies which indicate
that 5–80% of seropositive patients are asymptomatic. Therefore,
household-targeted serological testing can decrease biases arising
from selective testing, and generate concrete evidence on the role
of asymptomatic transmission of infection in rapidly increasing
infection rates (Kumar et al., 2020). Household transmission is of
particular concern in congested neighbourhoods of metropolitan
cities when lockdown measures are in place. Secondary transmission from index cases in households using prospective follow-up
and active symptom monitoring with nasopharyngeal polymerase
chain reaction (PCR) has indicated household attack rates as high
as 32.4% [95% conﬁdence interval (CI) 22.4–44.4%] (Wu et al.,
2020). However, this exercise is resource intensive, and transmission may differ between symptomatic and asymptomatic

Methods
Study participants and sample collection
This study was conducted in two areas. Four sub-administrative
units (union councils) of District East were selected as hightransmission areas based on the number of cases per million
reported by the provincial government (Figure 1). One union
council of District Malir was selected as a low-transmission area.
This study was approved by Aga Khan University Ethical Review
Committee.
Three cross-sectional surveys were performed sequentially at
household level between 15–25 April, 25 June–11 July and 17–22
August 2020 (Phases 1, 2 and 3, respectively). Four research teams,
each comprising one data collector and one phlebotomist,
collected data and serology samples. A detailed line list of cases
was available for District East, which enabled households to be
selected using systematic random sampling as follows: a case was
identiﬁed at random from the line list that served as a reference

Figure 1. Study area and total population.
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informed consent or assent from individual participants was
obtained.
All team members underwent training in the use of personal
protective equipment, hand hygiene and safe transportation of
biological samples. Blood samples (3 mL for infants, 5 mL for older
participants) were collected by a trained phlebotomist and
transported to the Infectious Diseases Research Laboratory for
centrifugation, serum separation and storage at 20  C. Information was collected from all participants on age, gender, occupation
and household size, along with details of travel history and
exposure to patients with COVID-19. Reported comorbidities,
presence of symptoms and history of hospitalization were also

point. From here, the direction was determined by spinning a
bottle or a pen, and the nth interval between structures was
identiﬁed using the second last digit of a bank note. The reference
household was not included in the survey. In the case of household
refusal to participate, the next household was approached.
Facilities such as hospitals, care homes, educational institutions
and prison were excluded. However, healthcare workers within a
household were not excluded. In District Malir, a line list of all
residential households was available, and simple random sampling
was used to select households. In both areas, all household
members were eligible to participate regardless of their infectious
status. Approval from the head of the household and written

Figure 2. Flow chart of participants in (A) Phase 1, (B) Phase 2 and (C) Phase 3.
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Estimation of overall, age-stratiﬁed and gender-stratiﬁed
seroprevalence
Age- and gender-stratiﬁed seroprevalence estimates were
computed for each district and each phase independently using
a Bayesian hierarchical regression model. This approach, described
in detail in the online Supplementary material, accounts for
uncertainty due to ﬁnite laboratory validation data (Larremore
et al., 2020a), and produces estimates using typical choices of
uninformative or weakly informative prior distributions (Gelman
and Carpenter, 2021; Larremore et al., 2020b).
Given the correlation between household seropositivity values,
the model also considered factors such as the total number of
household members, and adjusted for test accuracy by modelling
directly on the laboratory validation data reported by the test
manufacturer (Roche Diagnostics, 2020). Seroprevalence estimates
by age and gender were post-stratiﬁed to adjust for the
demographic make-up of the respective districts.
Estimates are expressed as posterior means and 95% CI based
on 20,000 samples from a Bayesian posterior distribution. All
calculations were performed using R Software, and samples from
posterior distributions were obtained using Stan (https://mcstan.org).

recorded. Participants were also asked about their occupational
history in terms of working from home or otherwise. For
symptoms, the clinical history recorded details of the presence
of fever, respiratory symptoms (e.g. sore throat, shortness of
breath) and chest pain in the preceding 2 months (Supplementary
Table 1, see online Supplementary material).
Laboratory analysis
A commercial Elecsys Anti-SARS-CoV-2 immunoassay (Roche
Diagnostics, Basel, Switzerland) targeting combined immunoglobulin (Ig) G and IgM against severe acute respiratory syndrome
coronavirus-2 was performed at the Nutritional Research Laboratory at Aga Khan University. The manufacturer reported speciﬁcity
>99.8% and sensitivity of 100% for individuals with a positive PCR
test at least 2 weeks previously, and 88.1% sensitivity for
individuals 7–13 days after a PCR-positive test (Roche Diagnostics,
2020).
Statistical analysis
Sample size
The sample size for each phase of the survey was calculated to
be 500 participants for each site. This allowed for estimation of
age-adjusted prevalence in the range of 20–30% with 95% CI, with
precision of 5% and a design effect of 1.5 for household-level
clustering.

Household conditional risk of infection and infection fatality rate
analysis
CRI is the probability that an individual is infected, conditioned
on a household member being infected (Curmei et al., 2020). CRI
was calculated and presented as a fraction, where the numerator
was the total number of ordered pairs among infected individuals
in the same household, and the denominator was the total number
of ordered pairs in the same household in which the ﬁrst individual
in the pair is infected. A 95% CI was estimated via bootstrap for each
area by resampling households with replacements.
Age-speciﬁc IFR estimates the prevalence of infection (including both asymptomatic and mildly symptomatic cases). The
cumulative number of deaths due to COVID-19 was calculated
until 14 days after dissemination of the serosurvey. This number
was divided by the ﬁgure obtained from multiplying the relevant

Data management
Data entry was performed in duplicate on a structured query
language database (My SQL, 2021), and was checked thoroughly for
completeness and consistency. Continuous variables such as age
and household size were reported as mean and standard deviation
(SD). Categorical variables such as gender, occupation and
symptoms were reported as frequency and percentage. Participants reporting fever or respiratory symptoms in the preceding 2
months were categorized as symptomatic and presented as
proportions. Age was also categorized.
Table 1
General characteristics of the study participants.
District East

Districts

District Malir

Characteristics

Phase 1 (n = 500)

Phase 2 (n = 500)

Phase 3 (n = 500)

Phase 1 (n = 500)

Phase 2 (n = 504)

Phase 3 (n = 501)

Gender, male, n (%)
Age in years, mean (SD)
Age group, years, n (%)
0–4
5–9
10–18
19–39
40–59
60
Household size, mean (SD)
Working outside home, n (%)
Comorbidities, n (%)
None
Diabetes
Hypertension
Asthma or allergy
Chronic hepatitis
Chronic heart disease
Asymptomatic
Sought care
Hospitalization
History of travel
Contact with suspected or conﬁrmed
cases of COVID-19

256 (51.2%)
26.2 (17.9%)

225 (45.0%)
25.9 (16.7%)

211 (42.2%)
27.1 (17.7%)

207 (41.4%)
28.5 (17.9%)

199 (39.5%)
24.32 (16.7%)

206 (41.1%)
26 (16.7%)

35 (7.0%)
57 (11.4%)
107 (21.4%)
185 (37.0%)
83 (16.6%)
33 (6.6%)
6.1 (4.17)
155 (31.0%)

22 (4.4%)
54 (10.8%)
139 (27.8%)
170 (34.0%)
97 (19.4%)
18 (3.6%)
6.6 (3.6)
145 (29.0%)

31 (6.2%)
56 (11.2%)
91 (18.2%)
206 (41.2%)
84 (16.8%)
32 (6.4%)
5.7 (2.3)
107 (21.4%)

26 (5.2%)
52 (10.4%)
86 (17.2%)
203 (40.6%)
103 (20.6%)
30 (6.0%)
6 (2.8)
143 (28.6%)

33 (6.6%)
74 (14.7%)
120 (23.9%)
186 (37.0%)
65 (12.9%)
25 (5.0%)
5.89 (3.2)
124 (24.6%)

29 (5.8%)
75 (15.0%)
87 (17.4%)
195 (38.9%)
90 (18.0%)
25 (5.0%)
5.6 (2.6)
116 (23.2)

453 (92.3%)
20 (4.0%)
14 (2.8%)
3 (0.6%)
2 (0.4%)
0 (0.0%)
435 (87.0%)
9 (1.8%)
1 (0.2%)
2 (0.4%)
1 (0.2%)

463 (93.0%)
14 (2.8%)
13 (2.6%)
3 (0.6%)
3 (0.6%)
3 (0.6%)
453 (90.6%)
9 (1.8%)
5 (1.0%)
11 (2.2%)
1 (0.2%)

471 (94.2%)
8 (1.6%)
16 (3.2%)
3 (0.6%)
1 (0.2%)
1 (0.2%)
471 (94.2%)
2 (0.4%)
0 (0%)
7 (1.4%)
2 (0.4%)

473 (94.6%)
6 (1.2%)
16 (3.2%)
1 (0.2%)
3 (0.6%)
1 (0.2%)
472 (94.4%)
3 (0.6%)
1 (0.2%)
8 (1.6%)
0 (0.0%)

479 (95.0%)
10 (2.0%)
11 (2.2%)
0 (0.0%)
3 (0.6%)
1 (0.2%)
487 (96.6%)
4 (0.8%)
0 (0.0%)
1 (0.2%)
1 (0.2%)

482 (96.2%)
5 (1.0%)
14 (2.8%)
0 (0.0%)
0 (0.0%)
1 (0.2%)
473 (94.4%)
0 (0.0%)
0 (0.0%)
4 (0.8%)
1 (0.2%)

COVID-19, coronavirus disease 2019; SD, standard deviation.
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population of an area with the adjusted estimate of seroprevalence
(Ioannidis, 2021).
Results
Participant ﬂow
In total, 3005 participants were enrolled across three phases
from District East and District Malir (Figure 2). There were high
refusal rates in both areas at household level: 68%, 43% and 61% in
District East and 44%, 42% and 8% in District Malir in Phases 1, 2
and 3, respectively. Amongst the households who agreed to
participate, the individual participation rate was 82.3% (1000 of
1215 eligible household members) in Phase 1, 76.5% (1004 of 1312
eligible household members) in Phase 2 and 80% (1001 of 1243
eligible household members) in Phase 3. Table 1 describes the
baseline demographic and clinical characteristics of the enrolled
participants.

Figure 3. Comparison of trends in coronavirus-disease-2019-positive cases from
District East and study sampling sites, and estimated seroprevalence in Phases 1, 2
and 3.

Seropositivity
Discussion
In Phase 1, only two of 500 samples tested positive in District
East, while none of the 500 participants tested positive in District
Malir. In Phase 2, 100 of 500 samples (20.0%) tested positive in
District East and 64 of 504 samples (12.7%) tested positive in
District Malir. In Phase 3, 119 of 500 samples (24%) tested positive
in District East and 79 of 501 samples (16%) tested positive in
District Malir.

This study used three serial cross-sectional surveys to
summarize the seroprevalence rates in two neighbourhoods of
Karachi, from the very early phase of the pandemic to the postpeak phase. Seroprevalence increased over time, with only a tiny
fraction of seropositive individuals reporting any symptoms. A
study from Karachi reported a seroprevalence rate of 17.5% among
workers across various occupational sectors, while a study from
Lahore reported a seroprevalence rate of 15.6% among police force
personnel (Chughtai et al., 2020; Javed et al., 2020). The National
Institute of Blood Disease in Karachi found an overall estimate of
36% among their participants that included industrial workers
(50% positivity), healthcare workers (13% positivity), general public
(15.6% positivity) and healthy blood donors (36% positivity) (Zaidi
et al., 2020). Preliminary reports of seroprevalence studies from
the international literature have highlighted high seroprevalence
rates in large metropolitan areas. A study from Mumbai, India
reported a seroprevalence rate of 55% (The Times of India, 2020),
while a survey carried out in Guilan Province, Iran reported a
seroprevalence rate of 33% at the peak of the pandemic
(Bhattacharyya et al., 2020; Shakiba et al., 2020).
The three serial serosurveys conducted in the same populations
in Karachi indicated an early increase in Phase 2 that continued
over the next few months, as demonstrated by Figure 3. A number
of reasons can explain this trend; Phase 1 of the study was
undertaken early in the pandemic, 3 weeks after a provincial
lockdown was declared, while Phase 2 was conducted after
lockdown measures were eased in anticipation of the religious
festivities observed during Eid in Pakistan. Although individual
associations cannot be discerned, the effectiveness of social
mitigation measures could explain the smaller increase in Phase 3.
The survey did not identify any difference in seroprevalence
between males and females, or any age-speciﬁc trends in infection
rates across different age categories. Prevalence appeared to
increase with age and was documented to be consistently high
between 19 and 39 years of age and 40 and 59 years of age in both
males and females. This is consistent with age-related seropositivity patterns in the literature (Nickbakhsh et al., 2020). The
survey found a large number of asymptomatic seropositive
individuals. Only three of 10 reported any respiratory symptoms,
with or without fever. In contrast to these ﬁndings, the proportion
of asymptomatic infections was reported to be much lower (27.7%,
95% CI 16.4–42.7%) in a meta-analysis (He et al., 2021). However,
higher rates of asymptomatic infection have been reported in some
parts of the world such as India. According to WHO and the Indian

Adjusted seroprevalence
In Phase 1, post-stratiﬁed seroprevalence was estimated to
be 0.4% (95% CI 0–1.3%) in District East and 0.2% (95% CI 0–0.7%)
in District Malir. In Phase 2, post-stratiﬁed seroprevalence was
estimated to be 15.1% (95% CI 9.4–21.7%) in District East and
8.7% (95% CI 5.1–13.1%) in District Malir. In Phase 3, poststratiﬁed seroprevalence was estimated to be 21.5% (95% CI
15.6–28%) in District East and 12.8 % (95% CI 8.3–17.7%) in
District Malir.
Both districts showed a marked, signiﬁcant increase in
seroprevalence between sequential phases, with a sharp increase
between Phases 1 and 2 and a smaller increase between Phases 2
and 3. Overall reporting of symptoms was documented to be 9.4%.
Of the total 364 participants who tested positive, 27 (7.4 %)
reported a history of fever, respiratory symptoms or both in the
preceding 2 months (Table S1, see online Supplementary material).
Conditional risk of infection and infection fatality rates
To measure whether individuals in the same household were
more likely to have similar serostatus, CRI was calculated for
Phases 2 and 3. CRI estimates were 0.41 (95% CI 0.28–0.52) and 0.38
(95% CI 0.27–0.52) in District East and 0.31 (95% CI 0.16–0.4) and
0.33 (95% CI 0.12–0.47) in District Malir in Phases 2 and 3,
respectively. In parallel, the age-speciﬁc IFR, calculated based on
the cumulative total of infected persons (based on seroprevalence)
and number of deaths (obtained from local government surveillance data), was calculated to be 1.66% in Phase 1, 0.37% in Phase 2
and 0.26%% in Phase 3.
The increase in seroprevalence in District East corresponded
with the epidemiology as ascertained through daily case reporting
in the district as well as the four study sampling sites (Figure 3).
Seropositivity rates were indistinguishable between males and
females within each district, as well as between age groups
(Table 2, represented graphically in Figure S1, see online
Supplementary material).
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Table 2
Age- and gender-based prevalence of coronavirus disease 2019 in District East and District Malir for Phases 2 and 3.a
Variables

Phase 2

Phase 3

Gender

Age (years)

District East

District Malir

District East

District Malir

Female
Female
Female
Female
Female
Female
Male
Male
Male
Male
Male
Male

0–4
5–9
10–18
19–39
40–59
60
0–4
5–9
10–18
19–39
40–59
60

0.14 (0.04–0.25)
0.13 (0.04–0.22)
0.13 (0.05–0.21)
0.15 (0.07–0.23)
0.15 (0.07–0.26)
0.15 (0.05–0.27)
0.14 (0.04–0.25)
0.13 (0.03–0.23)
0.17 (0.09–0.28)
0.15 (0.08–0.24)
0.22 (0.10–0.40)
0.14 (0.05–0.26)

0.08 (0.02–0.14)
0.09 (0.04–0.15)
0.09 (0.04–0.14)
0.10 (0.05–0.16)
0.08 (0.03–0.14)
0.01 (0.04–0.19)
0.08 (0.02–0.14)
0.08 (0.03–0.14)
0.01 (0.04–0.17)
0.08 (0.03–0.13)
0.08 (0.03–0.14)
0.09 (0.03–0.15)

0.20 (0.09–0.30)
0.20 (0.10–0.23)
0.20 (0.12–0.23)
0.24 (0.16–0.33)
0.23 (0.15–0.33)
0.21 (0.12–0.31)
0.19 (0.09–0.29)
0.19 (0.08–0.28)
0.22 (0.14–0.32)
0.22 (0.14–0.31)
0.22 (0.14–0.35)
0.21 (0.11–0.32)

0.13
0.13
0.12
0.13
0.14
0.13
0.12
0.12
0.14
0.12
0.13
0.13

a

(0.07–0.21)
(0.07–0.19)
(0.07–0.19)
(0.08–0.19)
(0.08–0.21)
(0.06–0.19)
(0.06–0.19)
(0.06–0.19)
(0.08–0.22)
(0.07–0.18)
(0.08–0.22)
(0.07–0.20)

Numbers are probability estimates with 95% CI.

Strengths of this study include the fact that it captured baseline
seropositivity at population level at the beginning of the pandemic
when transmission was low. Subsequent surveys at 2-monthly
intervals enabled sequential evaluation of changes in seroprevalence. At least one-third of the sample consisted of children aged
<18 years, thus focusing on an understudied age group in the
pandemic. Adaptation of the standardized WHO UNITY protocol
enables comparison of the results of this study with other studies
that have used the same protocol.
However, this study also had certain limitations. The geographical area of the study was limited to two neighbourhoods of
Karachi, Pakistan. Although Karachi is a large multi-ethnic, socioeconomically diverse metropolitan city (population 16 million), it
is deﬁnitely not representative of Pakistan as a whole. The sample
size did not allow comparison between the two neighbourhoods.
In addition, the rate of household-level refusal — which can result
in underestimation or overestimation of prevalence rates — was
high. Due to limited supply chain issues for test kits in Pakistan, inhouse validation on local samples was not undertaken; however,
this was compensated by modelling directly from the data
reported by the manufacturer.

Council of Medical Research, India, the number of asymptomatic
cases appears to be approximately 80% (Chatterjee et al., 2020).
Lower reporting of symptoms in Pakistan may be attributable to
innate fears of disclosure of disease positivity and lack of
awareness about the high transmissibility of the disease in the
general public in the early stages of the pandemic.
The increase in seroprevalence over time, even in an area of
presumed low transmission, indicates that seroprevalence studies
may serve as important tools to determine the spread of infection
in populations where a large majority of the people are
asymptomatic. Monitoring the general population through serial
serosurveys can detect resurgence, especially when lockdown
measures are eased, and enable policy makers to devise strategies
for containment of the disease. Heterogeneity between low- and
high-income neighbourhoods is likely and has been suggested
previously (Hooper et al., 2020; de Souza et al., 2020; Rafael et al.,
2020). In the present study, an alternate explanation for this could
be the different sampling strategy for the two districts. However, it
is difﬁcult to discern the direction in which this may bias the
results. Nevertheless, temporal trends within the districts can be
established from the present study.
These results also conﬁrm that close contact within households
is linked to a high probability of being infected, and should be an
important consideration in the transmission of SARS-CoV-2
(Pakistan Bureau of Statistics, 2021). This study indicated that
the probability of an individual acquiring an infection in the
presence of another infected household member, as measured by
CRI, was between 35% and 40%. An unpublished review which used
a secondary attack rate, which is a more reliable indicator of
intrahousehold transmission, reported this to be lower (18.8%, 95%
CI 15.4–22.2%) (Madewell et al., 2020). CRI can therefore function
as a substitute in situations where comprehensive surveillance
efforts and disease notiﬁcation strategy are absent, and where
secondary attack rates are difﬁcult to estimate.
This study indicated that the age-speciﬁc IFR was higher in
Phase 1 (1.66%), and decreased in Phases 2 and 3 to 0.37% and
0.26%, respectively. This may be attributed to early detection and
improved management of symptomatic disease. A systematic
review and meta-analysis conceded that overall IFR could be
0.68% (0.53–0.82%) due to heterogeneity from the studies
contributing to the review, or due to various factors such as
age and the presence of comorbidities in the population
(Meyerowitz-Katz and Merone, 2020). Population demographics
can affect estimates of population-weighted IFR, with the lowest
IFRs recorded for countries with younger populations, such as
Kenya (0.09%, 95% CI 0.08–0.10%) and Pakistan (0.16%, 95% CI 0.14–
0.19%) (O’Driscoll et al., 2021).

Conclusion
Seroprevalence increased in both neighbourhoods over time.
Most seropositive cases were reported to be asymptomatic. The
probability of an individual being infected following exposure
within the same household was high. IFR decreased over time.
Finally, serial cross-sectional surveys are valuable to monitor
population-level immunity against COVID-19 during the pandemic
and post-vaccine era.
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